The U.S. Drug Enforcement Administration says it plans on “keeping an eye on Canada” by opening two new offices in the country to track and intercept the flow of fentanyl into the U.S.

In a U.S. Senate hearing on May 12, Drug Enforcement Administration (DEA) Administrator Terrance Cole said the U.S. federal agency proposed the offices will be open by 2027 but did not specify where they will be located. However, the DEA has flagged Vancouver as a key entry point for fentanyl trafficking.

According to Cole, DEA teams have conducted “significant seizures of fentanyl in Canada” in the last two months, as they continue to target Mexican cartels that “have started producing and manufacturing fentanyl” north of the border.